Assessment a of a Disease management system with Medical devices In REnal disease
For patients with chronic illness, self-management is the key to determine clinical outcome. A Disease Management System that can offer all options necessary for self-management should incorporate newly medical devices for patients self-monitoring.
In the ADMIRE project we will allocate part of the control to patients themselves by introducing a new home-based medical device for measuring the creatinine level, by providing patients with options for home-based blood pressure measurements, and by providing a website for feedback and eLearning.
The prototype of the DMS will be tested in a Randomized Controlled Trial (RCT), with 50 patients in the control group and 50 patients in the intervention group. This RCT will provide information regarding safety (non-inferiority to regular care with respect to loss of renal function) and medical and psychological effectiveness, i.e. better self-management and higher degree of empowerment. Meanwhile, usablitity test and interviews will be conducted and provide information for improving the technological and usability aspects of the system. A model for upgrading this system for larger groups of renal transplant patients will be proposed. Furthermore, the results from ADMIRE will be translated into a best practice for implementation of a point of care creatinine measurement device in a DMS.